Swann E - Search Results

1

Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2.

Swann E, Barraja P, Oberlander AM, Gardipee WT, Hudnott AR, Beall HD, Moody CJ. Swann E, et al. J Med Chem. 2001 Sep 27;44(20):3311-9. doi: 10.1021/jm010884c. J Med Chem. 2001. PMID: 11563930

2

Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.

Newsome JJ, Swann E, Hassani M, Bray KC, Slawin AM, Beall HD, Moody CJ. Newsome JJ, et al. Among authors: swann e. Org Biomol Chem. 2007 May 21;5(10):1629-40. doi: 10.1039/b703370b. Epub 2007 Apr 20. Org Biomol Chem. 2007. PMID: 17571194

3

Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.

Newsome JJ, Hassani M, Swann E, Bibby JM, Beall HD, Moody CJ. Newsome JJ, et al. Among authors: swann e. Bioorg Med Chem. 2013 Jun 1;21(11):2999-3009. doi: 10.1016/j.bmc.2013.03.071. Epub 2013 Apr 6. Bioorg Med Chem. 2013. PMID: 23635904 Free PMC article.

4

Synthesis and biological activity of thiazolylindolequinones, analogues of the natural product BE 10988.

Moody CJ, Swann E, Houlbrook S, Stephens MA, Stratford IJ. Moody CJ, et al. Among authors: swann e. J Med Chem. 1995 Mar 17;38(6):1039-43. doi: 10.1021/jm00006a024. J Med Chem. 1995. PMID: 7699696

5

Novel bioreductive anticancer agents based on indolequinones.

Moody CJ, Swann E. Moody CJ, et al. Among authors: swann e. Farmaco. 1997 May;52(5):271-9. Farmaco. 1997. PMID: 9273997

6

Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.

Beall HD, Winski S, Swann E, Hudnott AR, Cotterill AS, O'Sullivan N, Green SJ, Bien R, Siegel D, Ross D, Moody CJ. Beall HD, et al. Among authors: swann e. J Med Chem. 1998 Nov 19;41(24):4755-66. doi: 10.1021/jm980328r. J Med Chem. 1998. PMID: 9822546

7

Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.

Beall HD, Hudnott AR, Winski S, Siegel D, Swann E, Ross D, Moody CJ. Beall HD, et al. Among authors: swann e. Bioorg Med Chem Lett. 1998 Mar 3;8(5):545-8. doi: 10.1016/s0960-894x(98)00069-9. Bioorg Med Chem Lett. 1998. PMID: 9871615

8

Cyclopropamitosenes, novel bioreductive anticancer agents. Synthesis, electrochemistry, and biological activity of 7-substituted cyclopropamitosenes and related indolequinones.

Cotterill AS, Moody CJ, Mortimer RJ, Norton CL, O'Sullivan N, Stephens MA, Stradiotto NR, Swann E, Stratford IJ. Cotterill AS, et al. Among authors: swann e. J Med Chem. 1994 Oct 28;37(22):3834-43. doi: 10.1021/jm00048a019. J Med Chem. 1994. PMID: 7966141

9

Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro.

Naylor MA, Swann E, Everett SA, Jaffar M, Nolan J, Robertson N, Lockyer SD, Patel KB, Dennis MF, Stratford MR, Wardman P, Adams GE, Moody CJ, Stratford IJ. Naylor MA, et al. Among authors: swann e. J Med Chem. 1998 Jul 16;41(15):2720-31. doi: 10.1021/jm970744w. J Med Chem. 1998. PMID: 9667963

10

Synthesis and cytotoxic activity of thiazolyl indolequinones.

Moody CJ, Roffey JR, Swann E, Lockyer S, Houlbrook S, Strafford IJ. Moody CJ, et al. Among authors: swann e. Anticancer Drugs. 1999 Jul;10(6):577-89. doi: 10.1097/00001813-199907000-00010. Anticancer Drugs. 1999. PMID: 10885906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters